Reports & Briefings

September 18, 2019
Policymakers should recognize that the potential of data-driven drug development is crucial to the well-being of Americans as well as U.S. competitiveness, and develop policies to accelerate this transformation.
September 12, 2019
The federal government should significantly increase spending on research and development that specifically targets technologies likely to boost productivity in order to spur growth and reduce the budget deficit.
September 9, 2019
Academic studies consistently show that a reduction in current drug revenues leads to a fall in future research and the number of new drug discoveries.
September 6, 2019
While tech issues may not be driving most voters to the polls, they will have a significant impact on the U.S. economy, including jobs and economic growth.
September 3, 2019
Policymakers should enable entry into the broadband market, but avoid undermining the dynamism of the sector by actively promoting additional competitors.
September 3, 2019
This briefing provides an update on energy research, development, and demonstration (RD&D) in the federal fiscal year (FY) 2020 appropriations process, building on ITIF’s summary of the administration’s budget request.
August 26, 2019
Since 2015, 24 nations and the EU have joined “Mission Innovation,” pledging to double public investments in energy RD&D and collaborate on key innovation challenges. This report seeks to provide accountability for these commitments and lay the foundation for more ambitious measures.
August 19, 2019
ITIF’s submission focuses on the ITC’s interest in recent developments in the digital economy for key SSA markets, including national and regional regulatory and policy measures and market conditions that affect digital trade.
August 19, 2019
The United States leads the race for global advantage in artificial intelligence, at least for the time being, with China coming in second and the EU lagging behind. But China is poised to challenge U.S. dominance in coming years as it undertakes bold AI initiatives.
August 12, 2019
China is challenging the United States for market share and jobs in one of the highest value-added, most innovation-intensive industries—and the risks extend not just to the U.S. economy, but to global biopharma innovation.

Pages